- Home
- MAXN vs AEON Comparison
MAXN vs AEON Comparison
Compare MAXN & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAXN | AEON |
|---|---|---|
| Founded | 2019 | N/A |
| Country | Singapore | United States |
| Employees | N/A | 5 |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.4M | 26.8M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | MAXN | AEON |
|---|---|---|
| Price | $1.55 | $0.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.20 |
| AVG Volume (30 Days) | ★ 5.3M | 71.0K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $100.37 | N/A |
| Revenue Next Year | $24.61 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.67 | $0.38 |
| 52 Week High | $4.97 | $1.45 |
Technical Indicators
Market Signals| Indicator | MAXN | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 46.70 | 42.31 |
| Support Level | $0.67 | $0.87 |
| Resistance Level | $3.82 | $1.12 |
| Average True Range (ATR) | 0.33 | 0.11 |
| MACD | 0.07 | -0.01 |
| Stochastic Oscillator | 69.76 | 16.99 |
Price Performance
Historical ComparisonAbout MAXN Maxeon Solar Technologies Ltd.
Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, Italy, and Rest of world.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.